exam number 2 pharm

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/13

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

14 Terms

1
New cards

anaplasia cancer property

losing normal function

2
New cards

autonomy cancer function

develop characteristics that allow them to grow in uninhabited way

3
New cards

metastasis

have ability to travel to other sites in body

4
New cards

angiogenesis

stimulate blood vessels to bring nutrients to cancer cells

5
New cards

4 properties of cancer

anaplasia, autonomy, metastasis, and angiogenesis

6
New cards

goal of chemotherapy

decrease size of the neoplasm/tumor so human immune can eliminate it

7
New cards

     Antineoplastic drugs destroy human cells. They are most likely to cause cell death among healthy cells that

have poor cell membranes

8
New cards

·       Patients taking NSAIDs should be taught to avoid the use of OTC medications without checking with their prescriber because

Many of the OTC preparations contain NSAIDs, and inadvertent toxicity could occur

9
New cards

An antipyretic is a drug that can

block fever

10
New cards

A drug could be classified as an analgesic if it

reduces pain

11
New cards

A client experiencing anxiety would present

tachycardia, tachypnea, dilated pupils, fear, and hypoactive bowel sounds

12
New cards

       Your client is taking a Barbituate, “Phenobarbital”. What is your priority assessment?

respiratory

13
New cards

       Your client is taking a MAOi, such as Isocarboxazid. What precautions would you educate on. (SATA)

dont take with TCA, avoid smoked meats, red wine and aged cheeses, and avoid fruits, figs and chocolates can be consumed in moderation

14
New cards

·       What are common side effects of anti-psychotic drugs?

dry mouth and glaucome